S. W. Choi

In vivo evaluation of the pulsatile ECLS sysem

Abstract Extracorporeal life support (ECLS) systems have been increasingly applied to groups of patients with cardiorespiratory failure, including pediatric and adult patients with respiratory failure. Current pulsatile ECLS systems use a single pulsatile blood pump that generates a high inlet pressure in the membrane oxygenator. To minimize this high inlet pressure, we have developed a new and improved ECLS system, twin pulse life support (T-PLS). To analyze the advantages of T-PLS, we have compared T-PLS with a single pulsatile ECLS system. An acute heart failure model was constructed by using a pulmonary artery banding technique. Fourteen pigs (22–31 kg) were used, with cardiac outputs of 2.0 l/min and a V/Q ratio set at 1. Cannulae of 28 Fr and 18 Fr were used in the right atrium and aorta, respectively. A polypropylene hollow-fiber membrane oxygenator and four polymer valves 30 mm in diameter were used in the T-PLS system. In the single pulsatile ECLS system, Medtronic Hall monostrut valves were used. To evaluate blood cell trauma in both pulsatile ECLS systems, plasma free hemoglobin (fHb) was measured while the systems were in use. The results show that fHb levels in T-PLS are lower than fHb levels in the single pulsatile ECLS system. There is a possibility that T-PLS could be used as an ECLS system for emergency situations.

Intelligent Li ion battery management based on a digital signal processor for a moving actuator total artificial heart.

An intelligent Li Ion battery management (ILBM) system was developed based on a digital signal processor (DSP). Instead of using relatively complicated hardware charging control, a DSP algorithm was used, and favorable characteristics in volume, mass, and temperature increase of the implantable battery were achieved. In vitro tests were performed to evaluate the DSP based algorithm for Li Ion charging control (24 V dc motor input power 16 W, 5 L/min, 100 mmHg afterload). In this article, the first improvement was volume reduction using a Li Ion battery (3.6 V/Cell, 900 mA, seven cells: 25.2 V, 22.7 W). Its volume and mass were decreased by 40% and 50% respectively (40*55*75 mm, 189 g), compared to previously reported results, with total energy capacity increased by 110% (more than 60 min vs 25 min run time in the other battery). The second improvement includes the ILBM, which can control the performance detection for each unit cell and has a low temperature rise. The ILBMs unit cell energy detection was important because the low performance of one cell dropped to 50% of the total performance along with a 20% increase in surface temperature. All electronics for a transcutaneous energy transmission (TET), battery, and telemetry were finalized for hybridization and used for total artificial heart (TAH) implantation. ASAIO Journal 1997; 43:M588-M592.

A Solar Cell System for Extension of Battery Run Time in a Moving Actuator Total Artificial Heart

An implantable total artificial heart (TAH) system has strong dependence upon the external battery performance for operation. Even under sophisticated battery management control, the usable external battery performance continues to decrease, which limits TAH performance. One of the ways to overcome this energy problem is to use a solar system (SS). An SS can provide electrical power for the partial TAH drive or battery recharge. This article presents a new concept for use of the solar cell for obtaining double external battery performance. To achieve it, numeric simulations were carried out to obtain the proper magnitude of solar parameters. In the TAH used, the battery power for a cardiac output of 4–6 L/min is ∼17 W/20 min. From simulated results, the optimal power and voltage of the SS were found to be 7 W, VOC = 27 V in the case of the 24 V motor. Each solar cell includes VOC = 0.5 V, ISC = 37 mA/cm2, FF (fill factor) = 0.77, and efficiency = 10%. Based on the simulation, the effect of solar power capacity on battery run time was studied. With use of 6.5 W SS (W 304 X H 245 X D 16 mm, 1.1 kg), battery performance decreased in vitro from 100% (fully charged) to >55% vs 0% in the conventional battery system after 20 min operation. However, it dropped to below 20% when using 2.5 W SS (W 192 X H 192 X D 16 cm, 0.6 kg). The results showed doubled battery run time could be obtained compared with a system without the SS. It was concluded that the proposed SS can be put to practical use as a future energy source for a TAH.

Development of counterpulsation algorithm for a moving-actuator type pulsatile LVAD.

A pulsatile left ventricular assist device (LVAD) was used to support the aortic blood pumping function of an injured left ventricle, and as a result helped its recovery. It is important to observe a left ventricles pumping status and to adjust the operating status of a LVAD to reduce the left ventricles pumping load and thus to enhance its recovery. To observe the left ventricles pumping status, an electrocardiogram (ECG) signal is generally used because it is a result of the natural hearts blood pumping function. In this paper, we describe the development of an ECG based counterpulsation control algorithm that prevents simultaneous aortic blood co-pumping by a left ventricle and a moving-actuator type pulsatile LVAD and as a result, reduces the natural hearts pumping load. In addition, to verify the algorithms applicability for LVAD control we designed three ECG based automatic pump control algorithms that use a developed counterpulsation control algorithm. These algorithms control the operating status of a LVAD automatically and, at the same time, maintain a counterpulsing status. The results of in vitro experiments show that the counterpulsing effect between a left ventricle and a LVAD was successfully produced and that the newly designed automatic pump control algorithms met their own control purposes with a counterpulsing effect.

Wireless patient monitoring system for a moving-actuator type artificial heart.

In this study, we developed a wireless monitoring system for outpatients equipped with a moving-actuator type pulsatile bi-ventricular assist device, AnyHeart™. The developed monitoring system consists of two parts; a Bluetooth-based short-distance self-monitoring system that can monitor and control the operating status of a VAD using a Bluetooth-embedded personal digital assistant or a personal computer within a distance of 10 meters, and a cellular network-based remote monitoring system that can continuously monitor and control the operating status of AnyHeart™ at any location. Results of in vitro experiments demonstrate the developed systems ability to monitor the operational status of an implanted AnyHeart™.

Self-management protocol for a moving-actuator type artificial heart

In this paper, we describe the development of a self-management protocol for a controller of a moving-actuator type artificial heart, AnyHeart™. The developed protocol analyzes motor current signals and detects abnormal pumping statuses. If preset abnormal pumping statuses are detected by an implemented algorithm, a controller triggers an emergency management procedure and transmits an alarm message to predetermined medical and engineering staffs via a cellular phone network to notify them of an abnormal pumping status occurrence and its likely cause. Results of in vitro performance experiments showed that the developed protocol can detect simulated abnormalities in motor current, manage the operating status of the blood pump during an emergency, and transmit an alarm message as desired.